News
GlobalData on MSN14h
RemeGen’s telitacicept achieves Phase III win in Sjögren’s syndrome
The drug met its primary endpoints in a Chinese trial, while a Phase III trial in Sjögren's syndrome is currently underway in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback